Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer Survivors
- Conditions
- Breast Cancer FemaleInsomnia
- Interventions
- Behavioral: Mindfulness-Based TherapyBehavioral: Cognitive Behavioral Therapy for Insomnia
- Registration Number
- NCT03328169
- Lead Sponsor
- George Washington University
- Brief Summary
Women with breast cancer who report insomnia that started or worsened during breast cancer diagnosis and treatment will be enrolled in a group behavioral trial to one of two arms testing cognitive behavioral therapy for insomnia against a mindfulness-based therapy.
- Detailed Description
The investigators are recruiting breast cancer survivors with stage I-III or Eastern Cooperative Oncology Group 0-1 breast cancer to enroll in a group-delivered behavioral trial for insomnia. The investigators are comparing mindfulness-based therapies delivered in an alternative medicine context to cognitive behavioral therapy for insomnia. The intervention is 9 weeks, for two hours weekly.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 26
- American Joint Committee on Cancer (AJCC) Stage I-III or Eastern Cooperative Oncology Group (ECOG) 0-1 breast cancer
- completed active treatment (surgery, radiation, chemotherapy) at least three months prior
- within 5 years of treatment or still on adjuvant therapy
- Completes informed consent to participate
- sleep apnea or restless leg syndrome
- practicing mindfulness techniques >1/wk
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mindfulness Mindfulness-Based Therapy Mindfulness-Based Therapy CBT-I Cognitive Behavioral Therapy for Insomnia Cognitive Behavioral Therapy for Insomnia
- Primary Outcome Measures
Name Time Method Change in Insomnia Nine weeks Measured using the Pittsburgh Sleep Quality Index (Scale 0-21; higher scores are worse)
- Secondary Outcome Measures
Name Time Method Change in cognitive function Nine weeks Measured via the Montreal Cognitive Assessment (MOCA)
Change in Fatigue Nine weeks Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue (Scale 8-40; higher is worse)
Change in Insomnia Nine weeks Measured using an actigraph
Trial Locations
- Locations (1)
GW Center for Integrative Medicine
🇺🇸Washington, District of Columbia, United States